Disclosure Of First-Time Adoption [Text Block]

GenSight Biologics S.A. - Filing #5982864

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
222 644 EUR
206 606 EUR
3 119 EUR
26 920 EUR
14 001 EUR
30,702,000 EUR
197,051,000 EUR
26,220,000 EUR
190,937,000 EUR
1,633,000 EUR
15,279,000 EUR
170,024,000 EUR
27,625,000 EUR
181,211,000 EUR
1,158,000 EUR
Comprehensive income
14 001 EUR
171,000 EUR
14 172 EUR
26,111,000 EUR
26,220,000 EUR
109,000 EUR
Profit (loss)
14 001 EUR
14 001 EUR
26,220,000 EUR
26,220,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.